Browse all Canadian datasets
Browse the complete CanQuery catalogue, including downloadable files, live tables and maps.
Open datasets
- Milton Boundary
- Wifi Locations
- Parks
- Road Segments
- Ward Boundaries
- Development Applications
- Cultural Spaces
- Magnetotelluric data archive
- 6 b Municipal Plan Amendment
- 6 a Main Lorentz.pdf
- 4 c Sandy Lane
- 4 b 124 Murphy
- 4 a 200 Robinson
- Agenda/Ordre du jour June22juin
- What we Heard Report: Consultations on the Implementation of the Indigenous Languages Act
- Heritage Notice
- Municipal Plan Amendment
- 58 Le Guerne
- Agenda Jun9juin ordre du jour
- 4 a 200 Robinson
- Clinical Trial Applications (CTAs) - requirements
- Clinical Trial Application - Amendments (CTA-As)
- Clinical Trial Applications for Biologics and Radiopharmaceuticals
- Biosimilar biologic drugs in Canada: Fact Sheet
- Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs
- Draft Guidance for Industry, Preparation of the Quality Information for Radiopharmaceuticals (Schedule C Drugs) using the Quality Information Summary-Radiopharmaceuticals (QIS-R) and Certified Product Information Document
- Guidance Document - Submission and Information Requirements for Extraordinary Use New Drugs (EUNDs)
- Guidance Document Harmonized Requirements for the Licensing of Vaccines and Guidelines for the Preparation of an Application
- Guidance document: Annual update of seasonal influenza vaccines
- Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Sex Differences
- Guidance Document: Fecal Microbiota Therapy Used in the Treatment of Clostridium difficile Infection Not Responsive to Conventional Therapies
- Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors
- Policy statement: Use of pharmacometrics in drug submissions and clinical trial applications
- Order to extend review period for clinical trial applications and amendments: Notice
- Guidance Document - Annex 13 to the Current Edition of the Good Manufacturing Practices Guidelines Drugs Used in Clinical Trials (GUI-0036)
- Guidance Document - Non-prescription Oral Adult Decongestant Cough and Cold Labelling Standard
- Guidelines for environmental control of drugs during storage and transportation (GUI-0069) - Summary
- Institution / Investigator Initiated Clinical Trials
- Notice - Publication of information about certain Clinical Trial Applications authorized by Health Canada
- Notice - Reconsideration of Decisions Issued for Human Drug Submissions
- Notice - Release of information about Medical Device Investigational Testing Applications authorized by Health Canada
- Overview of the Clinical Trial Application Process
- Post-Authorization Requirements
- Pre-Clinical Trial Application (CTA) Consultation Meeting
- Regulations amending the food and drug regulations (1024 - clinical trials)
- Review of your Application
- Submissions Containing Clinical Data from Studies Conducted outside of Canada
- Summary Report of Inspections of Clinical Trials Conducted from April 2004 to March 2011
- Guidance Document Definitions for Genomic Biomarkers, Pharmacogenomics, Pharmacogenetics, Genomic Data and Sample Coding Categories, ICH Topic E15
- Notice - Revision to Guidance Document: Submission of Pharmacogenomic Information